What does Preamble of HR 2767 do?

This bill aims to advance research for medical breakthroughs in brain tumor treatment. It also seeks to improve awareness and the adequacy of specialized cancer and brain tumor care.

What does SHORT TITLE; TABLE OF CONTENTS. of HR 2767 do?

This Act is formally titled the Bolstering Research And Innovation Now Act. The Act may also be referred to as the BRAIN Act.

What does Fostering transparency of biospecimen collections for brain of HR 2767 do?

This section addresses fostering transparency of biospecimen collections for brain cancer research.

What does Glioblastoma Therapeutics Network; brain tumor related cellular of HR 2767 do?

This section establishes a Glioblastoma Therapeutics Network. The network includes a team focused on brain tumor related cellular immunotherapy, including CAR-T. The section also provides for a science award related to these areas.

What does Cancer clinical trials and biomarker testing national public of HR 2767 do?

This section establishes a national public awareness campaign focused on cancer clinical trials and biomarker testing.

What does Pilot programs to develop, study, or evaluate approaches to of HR 2767 do?

This section establishes pilot programs focused on brain tumor survivors. The programs will develop, study, or evaluate approaches to monitoring and caring for this population.

What does FDA guidance to ensure brain tumor patient access to clinical of HR 2767 do?

This section addresses FDA guidance related to ensuring access for brain tumor patients to clinical trials.

What does FINDINGS; PURPOSES. of HR 2767 do?

This section outlines findings related to brain tumors, noting that over 1 million people in the United States are living with a brain tumor and approximately 94,000 were estimated to be diagnosed in 2023. The text highlights that brain tumors affect all demographics and are the leading cause of cancer-related death among children and young adults. Survival rates for malignant brain tumors have remained stagnant for 45 years, with low average survival rates. While most brain tumors are non-malignant, they often require treatment with varying outcomes. The text states that few treatments for brain tumors have been approved by the FDA, resulting in little change in mortality rates. Currently, there are no prevention or early detection protocols for brain tumors. The purposes of this Act include strengthening research and treatment development for brain tumors. The Act also aims to improve access to specialized brain tumor and rare cancer healthcare and increase awareness of such care.

What does FOSTERING TRANSPARENCY OF BIOSPECIMEN COLLECTIONS FOR BRAIN of HR 2767 do?

This section amends the Public Health Service Act to establish reporting requirements for brain tumor biospecimen collections. A 'covered biospecimen collection' is defined as a biospecimen collected or acquired with funding from the National Institutes of Health (NIH). The NIH Director may establish a website to make information about these collections publicly accessible, including their existence, location, and contact information. Entities maintaining collections as of the enactment date must submit a report to the NIH Director within 180 days. New collections acquired on or after the enactment date must be reported within 60 days. The NIH Director specifies the information required in these reports, at a minimum including what the National Cancer Institute requires for the Specimen Resource Locator. The Secretary, acting through the NIH Director, will establish an oversight mechanism, including potential withholding of funding for repeated or egregious violations.

What does GLIOBLASTOMA THERAPEUTICS NETWORK; BRAIN TUMOR RELATED CELLULAR of HR 2767 do?

This section amends the Public Health Service Act to establish the 'Glioblastoma Therapeutics Network' and the 'Brain Tumor Related Cellular Immunotherapy (Including CAR-T) Team Science Award'. The Glioblastoma Therapeutics Network will be a research program carried out by the Director of the Institute, utilizing cooperative agreements or other awards through the U19 funding mechanism to improve glioblastoma treatment. The program will focus on evaluating therapeutic agents from pre-clinical development through early-phase clinical trials. The Brain Tumor Related Cellular Immunotherapy Team Science Award aims to support a multi-institutional approach to using cellular immunotherapy, including CAR-T treatment, for adult and pediatric brain tumors. Funds for both programs are authorized at $50,000,000 annually for fiscal years 2026 through 2030, and $10,000,000 annually for the Brain Tumor Related Cellular Immunotherapy program, with funds remaining available until expended. The Director of the National Cancer Institute is directed to transition the existing Glioblastoma Therapeutics Network to the newly authorized program, ensuring consistency with existing policies and procedures.

Back to bills

BRAIN Act — HR. 2767

Last updated: 4/9/2025 · Introduced: 4/9/2025

Author: Brian Fitzpatrick (R-PA)

TL;DR (AI)

The BRAIN Act establishes a Glioblastoma Therapeutics Network to improve glioblastoma treatment by evaluating therapeutic agents through clinical trials.
It mandates reporting requirements for brain tumor biospecimen collections funded by the National Institutes of Health (NIH) to increase transparency and public accessibility.
The Act authorizes a national public awareness campaign to encourage discussions about cancer clinical trials and biomarker testing among healthcare providers and individuals.
It establishes pilot programs to develop and study approaches to monitoring and caring for brain tumor survivors, including culturally appropriate care and the use of artificial intelligence.
The bill directs the Food and Drug Administration (FDA) to issue guidance on minimizing the exclusion of brain tumor patients from clinical trials evaluating treatments for other conditions.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title; table of contents., and 11 more.

13 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account